Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02381717 · ClinicalTrials.gov registry record · NA

Ultrasound Guided Femoral Nerve Block

A NA study of Hip Fracture, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
44
Enrollment target
2
Study locations

NCT02381717 is a NA study of Hip Fracture that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 44 participants, below the 107-participant average among 5 other Hip Fracture trials with a reported enrollment target (59% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02381717, a NA study of Hip Fracture, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
2
Study locations

Study Summary

The goal of the study is to evaluate whether pain control achieved by Ultrasound Guided Femoral Nerve Blockade (USFNB) is equal in efficacy to standard pain management practice of parenteral injection of opioid pain medication in patients presenting to the emergency department (ED) with hip fracture.

Conditions Studied

Interventions

  • DRUG bupivacaine
  • DRUG morphine
  • OTHER ultra-sound guide

Study Locations (2)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston
  • St. Vincent's Hospital - Worcester

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2015-08
Est. Completion 2025-12
Phase NA

What the Registry Record Tells You About NCT02381717

The ClinicalTrials.gov registry entry for NCT02381717 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 107-participant average among 5 other Hip Fracture trials with a reported enrollment target (59% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hip Fracture appearing as the primary indexed condition, and to 3 interventions - of which bupivacaine is the first listed.

NCT02381717 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02381717 about?

NCT02381717 is a clinical study titled "Ultrasound Guided Femoral Nerve Block". The goal of the study is to evaluate whether pain control achieved by Ultrasound Guided Femoral Nerve Blockade (USFNB) is equal in efficacy to standard pain management practice of parenteral injection of opioid pain medication in patients presenting to the emergency department (ED) with hip fracture...

What is the current status of trial NCT02381717?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2015-08. Estimated completion is 2025-12.

What conditions does trial NCT02381717 study?

This clinical trial studies the following conditions: Hip Fracture.

What interventions are being tested in trial NCT02381717?

The interventions under investigation include: bupivacaine (DRUG), morphine (DRUG), ultra-sound guide (OTHER).

Who is sponsoring clinical trial NCT02381717?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02381717 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Fracture

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.